789397000: Upadacitinib (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Phosphotransferase inhibitor\Protein kinase inhibitor\Protein-tyrosine kinase inhibitor\Janus kinase inhibitor\Upadacitinib (substance)
\Substance categorized by disposition\Immunomodulator\Immunosuppressant (substance)\Upadacitinib (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Immunosuppressant (substance)\Upadacitinib (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Heterocyclic compound\Upadacitinib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3788860017 Upadacitinib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3788861018 Upadacitinib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Upadacitinib (substance)	Is a	Heterocyclic compound	true	Inferred relationship	Some
Upadacitinib (substance)	Is a	Janus kinase inhibitor	true	Inferred relationship	Some
Upadacitinib (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Janus kinase inhibitor (disposition)	true	Inferred relationship	Some
Upadacitinib (substance)	Is a	Immunosuppressant (substance)	true	Inferred relationship	Some
Upadacitinib (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	A substance that modifies the immune response or the functioning of the immune system.	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing upadacitinib (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Upadacitinib (substance)	Inferred relationship	Some	1
Product containing only upadacitinib (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Upadacitinib (substance)	Inferred relationship	Some	1
Upadacitinib-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Upadacitinib (substance)	Inferred relationship	Some	1
Product containing only upadacitinib in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Upadacitinib (substance)	Inferred relationship	Some	1
Product containing precisely upadacitinib 15 milligram/1 each prolonged-release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Upadacitinib (substance)	Inferred relationship	Some	1
Product containing precisely upadacitinib 15 milligram/1 each prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Upadacitinib (substance)	Inferred relationship	Some	1
Upadacitinib hemihydrate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Upadacitinib (substance)	Inferred relationship	Some
Upadacitinib anhydrous (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Upadacitinib (substance)	Inferred relationship	Some
Upadacitinib therapy	Direct substance	True	Upadacitinib (substance)	Inferred relationship	Some	1
Product containing precisely upadacitinib 30 milligram/1 each prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Upadacitinib (substance)	Inferred relationship	Some	1
Product containing precisely upadacitinib 30 milligram/1 each prolonged-release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Upadacitinib (substance)	Inferred relationship	Some	1

This concept is not in any reference sets